Research feed
Recently added diabetes research, organized by intervention and outcome.
Sorted by when Dediabetes added each study.
This study investigated the effects of coriander seed supplementation on glycemic indices and lipid profiles in patients with type 2 diabetes, finding significant reductions in several health markers.
This study compared long-term outcomes of laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass in patients with type 2 diabetes and obesity, revealing significant differences in anxiety and physical health scores.
This study explored the impact of non-surgical periodontal therapy on glycemic control in individuals with type 2 diabetes and periodontitis, finding a significant reduction in HbA1c levels.
This study explored a video game intervention aimed at enhancing diabetes-related numeracy but found no long-term benefits.
This study evaluated the effects of Vildagliptin on insulin resistance and weight reduction in newly diagnosed Type 2 Diabetes patients, showing significant improvements in several metabolic parameters.
This study compared the effects of pharmacological treatment, bariatric surgery, and a very-low-calorie diet on insulin resistance in patients with type 2 diabetes and hypertension, finding significant improvements in insulin resistance and weight loss with surgery and diet.
This study evaluated the use of insulin degludec and insulin aspart guided by a clinical decision support system for glycemic control in hospitalized patients with type 2 diabetes, finding a significant percentage of blood glucose measurements within target range.
This trial tested a carob-based liquid concentrate in people with confirmed prediabetes. After 90 days, the supplement group had better HbA1c, glucose responses, and insulin-related markers than the placebo group, with no adverse effects reported.
This study investigated the effects of cholecalciferol on depression in patients with type 2 diabetes, finding significant improvements in depression scores compared to placebo.
This study investigated the effects of dapagliflozin on cardiovascular outcomes in diabetic patients, revealing significant changes in plasma IL-1B and ketones.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.
